John Slattery

Co-Founder, CEO at BioROSA Technologies

John has been working on Autism Spectrum Disorder (ASD) clinical research since 2010. He was the clinical research program manager, co-investigator, and coordinated the clinical/translational autism research program under Dr. Richard E. Frye at Arkansas Children's Hospital Research Institute (ACRI). Richard, John, and their team at ACRI published 27 peer reviewed articles in Molecular Psychiatry, Translational Psychiatry, and other notable journals dedicated to their work on the metabolic basis of ASD. John co-founded BioROSA based on his clinical research experience and passion for building a new standard of care for patients with ASD.

Links

Previous companies

Multiple logo

Org chart

Sign up to view 2 direct reports

Get started